Evidence that the atypical 5‐HT<sub>3</sub> receptor ligand, [<sup>3</sup>H]‐BRL46470, labels additional 5‐HT<sub>3</sub> binding sites compared to [<sup>3</sup>H]‐granisetronLucinda J. Steward, Thomas P. Blackburn, P.C. Barber et al.|British Journal of Pharmacology|1995Cited by 30